Pathogens (Jun 2021)

SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia

  • Tatjana Vilibic-Cavlek,
  • Vladimir Stevanovic,
  • Maja Ilic,
  • Ljubo Barbic,
  • Krunoslav Capak,
  • Irena Tabain,
  • Jasna Lenicek Krleza,
  • Thomas Ferenc,
  • Zeljka Hruskar,
  • Renata Zrinski Topic,
  • Vanja Kaliterna,
  • Arlen Antolovic-Pozgain,
  • Jasmina Kucinar,
  • Iva Koscak,
  • Dijana Mayer,
  • Mario Sviben,
  • Ljiljana Antolasic,
  • Ljiljana Milasincic,
  • Lovro Bucic,
  • Ivana Ferencak,
  • Bernard Kaic

DOI
https://doi.org/10.3390/pathogens10060774
Journal volume & issue
Vol. 10, no. 6
p. 774

Abstract

Read online

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus with a pandemic spread. So far, a total of 349,910 SARS-CoV-2 cases and 7687 deaths were reported in Croatia. We analyzed the seroprevalence and neutralizing (NT) antibody response in the Croatian general population after the first (May–July 2020) and second (December 2020–February 2021) pandemic wave. Initial serological testing was performed using a commercial ELISA, with confirmation of reactive samples by a virus neutralization test (VNT). A significant difference in the overall seroprevalence rate was found after the first (ELISA 2.2%, VNT 0.2%) and second waves (ELISA 25.1%, VNT 18.7%). Seropositive individuals were detected in all age groups, with significant differences according to age. The lowest prevalence of NT antibodies was documented in the youngest (p < 0.001) was observed. SARS-CoV-2 NT antibody titers seem to be age-related, with the highest NT activity in children under 10 years and individuals above 50 years.

Keywords